Hims & Hers up 7% on raised 2024 revenue guidance, Q3 beats

filo Hims & Hers Health ( NYSE: HIMS ) is up ~7% in after-hours trading Monday after raising its 2024 revenue guidance and releasing Q3 financial results that beat on both lines. The telehealth platform now sees full-year revenue of $1.46B-$1.

465B, up from $1.37B-$1.4B prior.



Consensus is $1.4B..